Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 5, 2026, Robert Anderson and Roby Joyce informed the Board of Directors (the "Board") of bioAffinity Technologies, Inc., a Delaware corporation (the "Company"), of their decisions not to stand for re-election to the Board upon expiration of their current terms, which expire at the Company's 2026 Annual Meeting of Stockholders, currently scheduled for April 30, 2026 (the "Annual Meeting"). Mr. Anderson's and Mr. Joyce's decisions not to stand for re-election at the Annual Meeting did not result from any disagreements with the Company on any matter relating to the Company's operations, policies or practices.